Sökresultat - Tyner, Jeffrey

Phosphoproteomics microarray screen reveals novel interaction between MPL and Tensin2: Implications for biology, disease and therapeutics: Comment on: Jung AS, et al. Cell Cycle 20... av Tyner, Jeffrey W

Hämta fulltext Hämta fulltext Hämta fulltext

Rapid Identification of Therapeutic Targets in Hematologic Malignancies via Functional Genomics av Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Functional Genomics for Personalized Cancer Therapy av Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Integrating functional genomics to accelerate mechanistic personalized medicine av Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Immunoprecipitation of ROR1 av Bicocca, Vincent T., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext

ROR1 Flow Cytometry av Bicocca, Vincent T., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext

RNAi Screening of Leukemia Cells Using Electroporation av Agarwal, Anupriya, Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Next-Generation Medicine: Combining BCR-ABL and Hedgehog Targeted Therapies av Dao, Kim-Hien T., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Causal role for JAK2 V617F in thrombosis av Fleischman, Angela G., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

What’s different about atypical CML and chronic neutrophilic leukemia? av Dao, Kim-Hien T., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Genomics of chronic neutrophilic leukemia av Maxson, Julia E., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Keys to drug sensitivity from updated functional work flows av Kurtz, Stephen E., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment av Gotlib, Jason, Maxson, Julia E., George, Tracy I., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia av Watanabe-Smith, Kevin, Druker, Brian J., Tyner, Jeffrey W., Edwards, David K

Hämta fulltext Hämta fulltext Hämta fulltext

In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia av Glover, Jason M, Loriaux, Marc, Tyner, Jeffrey W, Druker, Brian J, Chang, Bill H

Hämta fulltext Hämta fulltext Hämta fulltext

PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma av Aslam, M. Imran, Abraham, Jinu, Mansoor, Atiya, Druker, Brian J., Tyner, Jeffrey W., Keller, Charles

Hämta fulltext Hämta fulltext Hämta fulltext

Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent av Leonard, Jessica T., Raess, Philipp W., Dunlap, Jennifer, Hayes-Lattin, Brandon, Tyner, Jeffrey W., Traer, Elie

Hämta fulltext Hämta fulltext Hämta fulltext

Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics av Tognon, Cristina E., Sears, Rosalie C., Mills, Gordon B., Gray, Joe W., Tyner, Jeffrey W.

Hämta fulltext Hämta fulltext Hämta fulltext

Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia av Bandyopadhyay, Shovik, Li, Junjie, Traer, Elie, Tyner, Jeffrey W., Zhou, Amy, Oh, Stephen T., Cheng, Ji-Xin

Hämta fulltext Hämta fulltext Hämta fulltext

Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia av Watanabe-Smith, Kevin, Tognon, Cristina, Tyner, Jeffrey W., Meijerink, Jules P.P., Druker, Brian J., Agarwal, Anupriya

Hämta fulltext Hämta fulltext Hämta fulltext